77.—(1) A protected cell company must ensure that the particulars specified in paragraph (3) are disclosed in all letters and e-mails sent, and in all other documents issued, by or on behalf of the protected cell company.
(2) If a protected cell company has a website, the protected cell company must also ensure that the particulars specified in paragraph (3) are disclosed on the website.
(3) The particulars mentioned in paragraphs (1) and (2) are—
(a)the protected cell company’s name;
(b)the protected cell company’s registered number;
(c)the protected cell company’s registered office;
(d)the fact that the protected cell company is a protected cell company registered by the FCA under the Risk Transformation Regulations 2017; and
(e)the fact that the assets, liabilities and obligations of the core and cells of the protected cell company are segregated in accordance with the Risk Transformation Regulations 2017.
(4) The particulars must be disclosed in characters that can be read with the naked eye.